Fall 2011

Fall 2011

Cancer Center Seminar Series

Fall 2011 Schedule 

Fridays 12:30-1:30pm
McKim Hall Auditorium, unless otherwise noted

The UVA Cancer Center presents this seminar series.  Refreshments will be served outside McKim Auditorium beginning at 12:00.

Please note, the Seminar Series is not being offered for CME credit.

September   October   November   December


Speaker and Title



C. Ryan Miller, MD, PhD
Assistant Professor, Department of Pathology and laboratory Medicine, Division of Neuropathology
University of North Carolina School of Medicine

Dissecting the Cellular and Molecular Requirements for Astrocytoma Initiation and Progression using Genetically-Engineered Mouse Models

Beatriz Lopes, MD
McKim Auditorium


Ross Cagan, PhD
Professor, Department of Developmental and Regenerative Biology
Associate Dean, Mount Sinai Graduate School of Biological Sciences Mount Sinai Medical Center

A Drosophila Approach towards Cancer Therapeutics

Ian Macara, PhD
McKim Auditorium


Tom Graeber, PhD
Assistant Professor, Molecular and Medical Pharmacology
Crump Institute for Molecular Imaging, UCLA

Leukemic Bcr-Abl and Src Signaling: Unbiased Phosphoprofiling Points to Crosstalk Mediated by Negative Feedback Mechanisms

Cameron Mura, PhD
McKim Auditorium



Neil Spector, MD
Associate Professor, Medicine and Pharmacology/Cancer Biology, Director of the Duke Translational Research in Oncology
Duke University

Dissecting the Complex Biology of Therapeutic Resistance to HER2 Small Molecule Tyrosine Kinase Inhibitor

Deric Park, MD
McKim Auditorium

Chris Touloukian, MD
Assistant Professor, Department of Surgery
IU Simon Cancer Center

Durable Immunity, Autoimmunity, and Tumor Eradication Following LV Modification of HSCs: The Development of a Novel Therapy for Patients with Metastatic Melanoma

Craig Slingluff, MD
McKim Auditorium


National Cancer Institute Presentation
Joel Morris, PhD

Chief, Drug Synthesis and Chemistry Branch
Developmental Therapeutics Program
National Cancer Institute

Drug Discovery at the National Cancer Institute

Beverly Teicher, PhD
Chief, Molecular Pharmacology Branch
Developmental Therapeutics Program
National Cancer Institute

Disease-directed Drug Discovery Initiatives in Sarcoma and Small Cell Lung Cancer

John Lazo, PhD
Jordan Hall, Room 117


Roger Abounader, MD, PhD
Associate Professor, Department of Microbiology
University of Virginia

Identification and Exploitation of Master Regulatory MicroRNAs in Glioblastoma: An Emerging Program Project

Sally Parsons, PhD McKim Auditorium


John Sweetenham, MD, FRCP
Professor of Medicine and Director of Clinical Research
Cleveland Clinic

Diffuse Large B-cell Lymphoma -
Clinical Utility of Molecular Subtypes

Michael Williams, MD
McKim Auditorium

Yali Dou, PhD
Assistant Professor, Department of Pathology and Biological Chemistry
University of Michigan

Many Facets of Histone Acetyltransferase MOF

Hui Li, PhD
McKim Auditorium




Hui Zong, PhD
Assistant Professor of Biology
University of Oregon

Elucidate Tumorigenic Process with MADM, a Mouse Genetic Mosaic System

Kevin, Janes, PhD
McKim Auditorium


Mark Jameson, MD, PhD, FACS
Assistant Professor, Division of Head and Neck Surgical Oncology, Department of Otolaryngology - Head and Neck Surgery
University of Virginia

Samhita Chakraborty, MD

Fellow Physician, Division of Hematology Oncology
University of Virginia

Targeting the IGF-1 Receptor in Cancer: Teaching an Old Dog New Tricks

Sally Parsons, PhD
McKim Auditorium


Todd Bauer, MD
Assistant Professor, Department of Surgery

Sally Parsons, PhD
McKim Auditorium

Back to Top Seminar Series Home